Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-06-18

Clinical Trial Update: The Role of Serum Leptin Levels in Multiple Sclerosis Disease Activity While on Interferon Beta 1a (Rebif) Treatment

View source ↗

Summary

A completed clinical trial evaluating whether serum leptin levels correlate with multiple sclerosis disease activity in patients treated with interferon beta-1a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rebif (interferon beta-1a)

Snippet

Sponsor: University of South Florida | Conditions: Multiple Sclerosis | Status: COMPLETED